Skip to content

AccuTrak 2400-0253

by LGC Clinical Diagnostics, Inc.

AccuTrak 2400-0253 is a thyroglobulin antibody IVD (FDA Class I; FDA product code JJX, Single (Specified) Analyte Controls (Assayed And Unassayed)) made by LGC Clinical Diagnostics, Inc., listed in FDA GUDID since 7 Jan 2025 (UDI-DI 00850011135686), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00850011135686 UDI-DI Date7 Jan 2025ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
AccuTrak
Generic name
Thyroglobulin antibody IVD, control
Model / reference
2400-0253
Primary DI / UDI-DI
00850011135686
FDA product code
JJX
GMDN term
Thyroglobulin antibody IVD, control
Device class
Class I
Regulation number
862.1660
GUDID distribution status
In Commercial Distribution

Other devices from LGC Clinical Diagnostics, Inc.

See all devices from LGC Clinical Diagnostics, Inc. →

Properties

  • Convenience kit
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)